Piompride 30 mg/4 mg 30 tablets
Averroes Pharma
Averroes Pharma
Composition:
Each tablet contains Pioglitazone 30 mg and Glimepiride 4 mg.
Product Description:
Piompride is an oral antidiabetic preparation combining pioglitazone (a thiazolidinedione) and glimepiride (a sulfonylurea).
It improves glycemic control in patients with type 2 diabetes mellitus by enhancing insulin sensitivity and stimulating insulin secretion.
Indications for Use:
Piompride is indicated for the management of type 2 diabetes mellitus in patients insufficiently controlled by diet, exercise, or monotherapy.
Method of Administration and Dosage:
Administered orally once daily, preferably before meals.
Dosage is individualized based on patient’s glycemic response.
Contraindications:
Contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe hepatic impairment, or hypersensitivity to pioglitazone, glimepiride, or excipients.
Precautions:
Caution in patients with heart failure, hepatic dysfunction, or risk of hypoglycemia.
Regular monitoring of blood glucose and liver function is recommended.
Adverse Reactions:
Possible side effects include hypoglycemia, weight gain, edema, headache, and gastrointestinal upset.
Rarely, hepatotoxicity or heart failure may occur.
Pregnancy and Lactation:
Not recommended during pregnancy or lactation.
Insulin is preferred for glycemic control in these conditions.
Storage Conditions:
Store below 25°C in a dry place, protected from moisture and light.
Keep out of reach of children.
Packaging:
Supplied in a box containing 3 strips of 10 tablets each.